Show simple item record

dc.contributor.authorAkintola, A
dc.contributor.authorYoussef, M
dc.contributor.authorOh, S
dc.contributor.authorByrne, D
dc.contributor.authorListon, R
dc.date.accessioned2014-07-17T11:54:32Z
dc.date.available2014-07-17T11:54:32Z
dc.date.issued2014-06
dc.identifier.citationAkintola, A, Youssef, M, Oh, S, Byrne, D, Liston, R "The burden of cost- admission versus discharge medications" IMJ Vol. 107 No.6 July 2014en_GB
dc.identifier.urihttp://hdl.handle.net/10147/323316
dc.description.abstractSir, Avoiding unnecessary polypharmacy prevents potential drug-drug interactions culminating in adverse drug events. 1 Medication review is an important opportunity for rationalizing a patientâ s treatment to maximize therapy for established chronic disease and minimize the potential for drug-drug and drug-disease interaction. A secondary consideration is the potential for a drug review to identify the possibility of cost saving by noting those occasions where generic substitution could occur without detriment to the patients overall therapy. We completed an audit of drug costs of medications for patients on admission and on discharge from an acute general hospital. The charts of the first 94 medical patients admitted into an acute general hospital starting from January 1st 2012 were sourced from Hospital In-Patient Enquiry (HIPE) and a pre-designed questionnaire was completed for each of these patients. The cost of medications per patient was calculated using the MIMMS manual appropriate for the period of admission and discharge. We examined the patient demographics, source of referral, LOS (length of stay), admission diagnosis, past medical history and names of medications and their individual costs.
dc.language.isoenen
dc.publisherIrish Medical Journalen_GB
dc.titleThe burden of cost- admission versus discharge medicationsen_GB
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen_GB
dc.description.fundingNo fundingen
dc.description.provinceMunsteren
dc.description.peer-reviewpeer-reviewen
refterms.dateFOA2018-08-24T11:52:57Z
html.description.abstractSir, Avoiding unnecessary polypharmacy prevents potential drug-drug interactions culminating in adverse drug events. 1 Medication review is an important opportunity for rationalizing a patientâ s treatment to maximize therapy for established chronic disease and minimize the potential for drug-drug and drug-disease interaction. A secondary consideration is the potential for a drug review to identify the possibility of cost saving by noting those occasions where generic substitution could occur without detriment to the patients overall therapy. We completed an audit of drug costs of medications for patients on admission and on discharge from an acute general hospital. The charts of the first 94 medical patients admitted into an acute general hospital starting from January 1st 2012 were sourced from Hospital In-Patient Enquiry (HIPE) and a pre-designed questionnaire was completed for each of these patients. The cost of medications per patient was calculated using the MIMMS manual appropriate for the period of admission and discharge. We examined the patient demographics, source of referral, LOS (length of stay), admission diagnosis, past medical history and names of medications and their individual costs.


Files in this item

Thumbnail
Name:
Article7563.pdf
Size:
3.847Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record